HEADER TRANSFERASE 28-AUG-15 5DGM TITLE CRYSTAL STRUCTURE OF HUMAN FPPS IN COMPLEX WITH MONOPHOSPHONATE TITLE 2 COMPOUND 7 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FARNESYL PYROPHOSPHATE SYNTHASE; COMPND 3 CHAIN: F; COMPND 4 FRAGMENT: RESIDUES 72-419; COMPND 5 SYNONYM: FPS,(2E,6E)-FARNESYL DIPHOSPHATE SYNTHASE, COMPND 6 DIMETHYLALLYLTRANSTRANSFERASE,FARNESYL DIPHOSPHATE SYNTHASE, COMPND 7 GERANYLTRANSTRANSFERASE; COMPND 8 EC: 2.5.1.10,2.5.1.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FDPS, FPS, KIAA1293; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: TUNER; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS TRANSFERASE, ISOPRENE BIOSYNTHESIS, CHOLESTEROL BIOSYNTHESIS EXPDTA X-RAY DIFFRACTION AUTHOR J.M.RONDEAU,E.BOURGIER,S.LEHMANN REVDAT 3 08-MAY-24 5DGM 1 REMARK REVDAT 2 20-JUL-16 5DGM 1 JRNL REVDAT 1 13-JUL-16 5DGM 0 JRNL AUTH W.JAHNKE,G.BOLD,A.L.MARZINZIK,S.OFNER,X.PELLE,S.COTESTA, JRNL AUTH 2 E.BOURGIER,S.LEHMANN,C.HENRY,R.HEMMIG,F.STAUFFER, JRNL AUTH 3 J.C.HARTWIEG,J.R.GREEN,J.M.RONDEAU JRNL TITL A GENERAL STRATEGY FOR TARGETING DRUGS TO BONE. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 54 14575 2015 JRNL REFN ESSN 1521-3773 JRNL PMID 26457482 JRNL DOI 10.1002/ANIE.201507064 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH W.JAHNKE,J.M.RONDEAU,S.COTESTA,A.MARZINZIK,X.PELLE,M.GEISER, REMARK 1 AUTH 2 A.STRAUSS,M.GOETTE,F.BITSCH,R.HEMMIG,C.HENRY,S.LEHMANN, REMARK 1 AUTH 3 J.F.GLICKMAN,T.P.RODDY,S.J.STOUT,J.R.GREEN REMARK 1 TITL ALLOSTERIC NON-BISPHOSPHONATE FPPS INHIBITORS IDENTIFIED BY REMARK 1 TITL 2 FRAGMENT-BASED DISCOVERY REMARK 1 REF NAT. CHEM. BIOL. V. 6 660 2010 REMARK 1 REFN ISSN 1552-4450 REMARK 1 PMID 20711197 REMARK 1 DOI 10.1038/NCHEMBIO.421 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.L.MARZINZIK,R.AMSTUTZ,G.BOLD,E.BOURGIER,S.COTESTA, REMARK 1 AUTH 2 J.F.GLICKMAN,M.GOTTE,C.HENRY,S.LEHMANN,J.C.HARTWIEG,S.OFNER, REMARK 1 AUTH 3 X.PELLE,T.P.RODDY,J.M.RONDEAU,F.STAUFFER,S.J.STOUT,A.WIDMER, REMARK 1 AUTH 4 J.ZIMMERMANN,T.ZOLLER,W.JAHNKE REMARK 1 TITL DISCOVERY OF NOVEL ALLOSTERIC NON-BISPHOSPHONATE INHIBITORS REMARK 1 TITL 2 OF FARNESYL PYROPHOSPHATE SYNTHASE BY INTEGRATED LEAD REMARK 1 TITL 3 FINDING. REMARK 1 REF CHEMMEDCHEM V. 10 1884 2015 REMARK 1 REFN ESSN 1860-7187 REMARK 1 PMID 26381451 REMARK 1 DOI 10.1002/CMDC.201500338 REMARK 2 REMARK 2 RESOLUTION. 2.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 1.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.86 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 54.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 11497 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.960 REMARK 3 FREE R VALUE TEST SET COUNT : 1145 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.86 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.92 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2690 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1994 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2442 REMARK 3 BIN R VALUE (WORKING SET) : 0.1910 REMARK 3 BIN FREE R VALUE : 0.2857 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.22 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 248 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2774 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 33 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 65.24 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.44860 REMARK 3 B22 (A**2) : 7.44860 REMARK 3 B33 (A**2) : -14.89730 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.320 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.321 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.936 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.905 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2864 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3883 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1018 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 82 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 404 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2864 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 357 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3598 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.08 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.50 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.66 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { F|* } REMARK 3 ORIGIN FOR THE GROUP (A): 10.3024 79.7587 27.4896 REMARK 3 T TENSOR REMARK 3 T11: -0.3316 T22: -0.2553 REMARK 3 T33: 0.1338 T12: -0.0277 REMARK 3 T13: 0.0310 T23: 0.0095 REMARK 3 L TENSOR REMARK 3 L11: 3.0486 L22: 2.4886 REMARK 3 L33: 2.6820 L12: 0.8834 REMARK 3 L13: -2.0112 L23: -0.7812 REMARK 3 S TENSOR REMARK 3 S11: -0.2174 S12: -0.1408 S13: -0.3227 REMARK 3 S21: 0.0583 S22: 0.0221 S23: 0.3044 REMARK 3 S31: 0.1924 S32: -0.0229 S33: 0.1953 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5DGM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-AUG-15. REMARK 100 THE DEPOSITION ID IS D_1000213149. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-JUN-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 92 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS DECEMBER 2004 REMARK 200 DATA SCALING SOFTWARE : XSCALE DECEMBER 2003 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11498 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.860 REMARK 200 RESOLUTION RANGE LOW (A) : 78.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 13.70 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.0500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.86 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.96 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.44300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.290 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS CNX 2005 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.2M SODIUM POTASSIUM PHOSPHATE, 25% REMARK 280 GLYCEROL, PH 4.7, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.38750 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 55.36150 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 55.36150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 19.19375 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 55.36150 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 55.36150 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 57.58125 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 55.36150 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.36150 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 19.19375 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 55.36150 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.36150 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 57.58125 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 38.38750 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4630 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29160 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 110.72300 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 110.72300 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 38.38750 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY F 4 REMARK 465 PRO F 5 REMARK 465 ASN F 6 REMARK 465 SER F 7 REMARK 465 ARG F 351 REMARK 465 ARG F 352 REMARK 465 LYS F 353 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO F 74 -17.50 -46.96 REMARK 500 VAL F 124 -85.87 -98.12 REMARK 500 ALA F 178 74.98 -116.96 REMARK 500 THR F 201 -58.97 -128.59 REMARK 500 GLU F 288 -72.84 -88.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 59Z F 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 F 402 DBREF 5DGM F 6 353 UNP P14324 FPPS_HUMAN 72 419 SEQADV 5DGM GLY F 4 UNP P14324 EXPRESSION TAG SEQADV 5DGM PRO F 5 UNP P14324 EXPRESSION TAG SEQRES 1 F 350 GLY PRO ASN SER ASP VAL TYR ALA GLN GLU LYS GLN ASP SEQRES 2 F 350 PHE VAL GLN HIS PHE SER GLN ILE VAL ARG VAL LEU THR SEQRES 3 F 350 GLU ASP GLU MET GLY HIS PRO GLU ILE GLY ASP ALA ILE SEQRES 4 F 350 ALA ARG LEU LYS GLU VAL LEU GLU TYR ASN ALA ILE GLY SEQRES 5 F 350 GLY LYS TYR ASN ARG GLY LEU THR VAL VAL VAL ALA PHE SEQRES 6 F 350 ARG GLU LEU VAL GLU PRO ARG LYS GLN ASP ALA ASP SER SEQRES 7 F 350 LEU GLN ARG ALA TRP THR VAL GLY TRP CYS VAL GLU LEU SEQRES 8 F 350 LEU GLN ALA PHE PHE LEU VAL ALA ASP ASP ILE MET ASP SEQRES 9 F 350 SER SER LEU THR ARG ARG GLY GLN ILE CYS TRP TYR GLN SEQRES 10 F 350 LYS PRO GLY VAL GLY LEU ASP ALA ILE ASN ASP ALA ASN SEQRES 11 F 350 LEU LEU GLU ALA CYS ILE TYR ARG LEU LEU LYS LEU TYR SEQRES 12 F 350 CYS ARG GLU GLN PRO TYR TYR LEU ASN LEU ILE GLU LEU SEQRES 13 F 350 PHE LEU GLN SER SER TYR GLN THR GLU ILE GLY GLN THR SEQRES 14 F 350 LEU ASP LEU LEU THR ALA PRO GLN GLY ASN VAL ASP LEU SEQRES 15 F 350 VAL ARG PHE THR GLU LYS ARG TYR LYS SER ILE VAL LYS SEQRES 16 F 350 TYR LYS THR ALA PHE TYR SER PHE TYR LEU PRO ILE ALA SEQRES 17 F 350 ALA ALA MET TYR MET ALA GLY ILE ASP GLY GLU LYS GLU SEQRES 18 F 350 HIS ALA ASN ALA LYS LYS ILE LEU LEU GLU MET GLY GLU SEQRES 19 F 350 PHE PHE GLN ILE GLN ASP ASP TYR LEU ASP LEU PHE GLY SEQRES 20 F 350 ASP PRO SER VAL THR GLY LYS ILE GLY THR ASP ILE GLN SEQRES 21 F 350 ASP ASN LYS CYS SER TRP LEU VAL VAL GLN CYS LEU GLN SEQRES 22 F 350 ARG ALA THR PRO GLU GLN TYR GLN ILE LEU LYS GLU ASN SEQRES 23 F 350 TYR GLY GLN LYS GLU ALA GLU LYS VAL ALA ARG VAL LYS SEQRES 24 F 350 ALA LEU TYR GLU GLU LEU ASP LEU PRO ALA VAL PHE LEU SEQRES 25 F 350 GLN TYR GLU GLU ASP SER TYR SER HIS ILE MET ALA LEU SEQRES 26 F 350 ILE GLU GLN TYR ALA ALA PRO LEU PRO PRO ALA VAL PHE SEQRES 27 F 350 LEU GLY LEU ALA ARG LYS ILE TYR LYS ARG ARG LYS HET 59Z F 401 25 HET PO4 F 402 5 HETNAM 59Z {2-[(PHOSPHONOMETHYL)CARBAMOYL]-1H-BENZO[G]INDOL-1- HETNAM 2 59Z YL}ACETIC ACID HETNAM PO4 PHOSPHATE ION FORMUL 2 59Z C16 H15 N2 O6 P FORMUL 3 PO4 O4 P 3- FORMUL 4 HOH *33(H2 O) HELIX 1 AA1 ASP F 8 THR F 29 1 22 HELIX 2 AA2 HIS F 35 GLU F 37 5 3 HELIX 3 AA3 ILE F 38 ALA F 53 1 16 HELIX 4 AA4 TYR F 58 VAL F 72 1 15 HELIX 5 AA5 ASP F 78 ASP F 107 1 30 HELIX 6 AA6 TRP F 118 LYS F 121 5 4 HELIX 7 AA7 VAL F 124 LEU F 126 5 3 HELIX 8 AA8 ASP F 127 ARG F 148 1 22 HELIX 9 AA9 TYR F 152 ALA F 178 1 27 HELIX 10 AB1 THR F 189 THR F 201 1 13 HELIX 11 AB2 THR F 201 PHE F 206 1 6 HELIX 12 AB3 PHE F 206 GLY F 218 1 13 HELIX 13 AB4 GLY F 221 GLY F 250 1 30 HELIX 14 AB5 ASP F 251 GLY F 256 1 6 HELIX 15 AB6 ASP F 261 ASN F 265 5 5 HELIX 16 AB7 SER F 268 ARG F 277 1 10 HELIX 17 AB8 THR F 279 TYR F 290 1 12 HELIX 18 AB9 GLU F 294 LEU F 308 1 15 HELIX 19 AC1 ASP F 309 ALA F 333 1 25 HELIX 20 AC2 PRO F 338 TYR F 349 1 12 SHEET 1 AA1 2 THR F 111 ARG F 112 0 SHEET 2 AA1 2 GLN F 115 ILE F 116 -1 O GLN F 115 N ARG F 112 CISPEP 1 ALA F 334 PRO F 335 0 4.98 SITE 1 AC1 9 TYR F 10 LYS F 57 ASN F 59 THR F 63 SITE 2 AC1 9 SER F 205 PHE F 206 PHE F 239 LEU F 344 SITE 3 AC1 9 ILE F 348 SITE 1 AC2 4 GLY F 56 LYS F 57 ARG F 113 HOH F 509 CRYST1 110.723 110.723 76.775 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009032 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009032 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013025 0.00000